Patent details

92117 Product Name: Méthanesulfonate d'éthylester d'acide 3-[(2-{[4-(hexyloxy-carbonylamino-imino-méthyl)-phénylamino]-méthyl}-1-méthyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-proprionique.

Basic Information

Publication number:
92117
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP037433687
Legal Status:
Lapsed
Application number:
92117
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/08/442/009-014 -Pradaxa-Dabigatran etexilate
Marketing Authorization Type:
Marketing Authorization Date:
18/01/2011
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
19/12/2012
First Marketing Authorization date:
18/01/2011
Grant date:
19/02/2013
Activation date:
03/03/2023
Publication date:
19/02/2013
Lapsed date:
Expiration date:
Renunciation date:
09/03/2016
Revocation date:
Annulment date:
Basic SPC Expiration:
18/01/2026
SPC Extension Expiration:
18/01/2026
Rejection date:
Withdrawal date:

Owner

From:
19/12/2012
 
 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Agent

Name:
ARONOVA S.A.
From:
19/12/2012
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
BRAUNS Ulrich
Address:
Germany (DE)

2

Name:
HAUEL Norbert
Address:
Germany (DE)

Other

Note:
Renonciation au CCP enregistrée le 09/03/2016 / SPC renunciation registered on 09/03/2016.
Filing date Document type Number of pages